Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
7.48
-0.07 (-0.86%)
Aug 25, 2025, 4:00 PM - Market closed
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $23.76 million as of August 25, 2025. Its market cap has decreased by -53.16% in one year.
Market Cap
23.76M
Enterprise Value
-8.99M
1-Year Change
-53.16%
Ranking
Category
Stock Price
$7.48
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $23.76M, a decrease of -97.52%. That is a compound annual growth rate of -49.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 23.97M | -31.58% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | 1.16B | 21.70% |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |